Synovial Fibroblast 3.2: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis-diagnosed donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 2 of 2) - Dataset (ID:20235)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2759 | Tofacitinib | 0.3 | uM | 3 | TNFb | 39.0 | 55 | ||||
N2759 | 3 | TNFb | 38.0 | 48 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 3 | TNFb | 32.0 | 49 | ||||
RA1931 | 3 | TNFb | 35.5 | 44 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 3 | TNFb | 33.5 | 52 | ||||
N2586 | 3 | TNFb | 40.0 | 56 | |||||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 32.5 | 52 | |
RA1869 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 34.0 | 50 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 45.0 | 70 | |
N2759 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 38.0 | 59 | |
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 36.0 | 72 | |
RA1931 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 52.5 | 72 | |
N2586 | 5z-7-oxozeaenol | 0.6 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 35.0 | 67 | |
N2586 | IKK16 | 2.0 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 32.0 | 60 | |
RA1869 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 34.0 | 55 | |
RA1869 | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 27.0 | 68 | ||||
N2759 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 36.0 | 54 | |
N2759 | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 46.0 | 54 | ||||
RA1931 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 31.0 | 35 | |
RA1931 | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 31.0 | 54 | ||||
N2586 | Tofacitinib | 0.3 | uM | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 36.0 | 41 | |
N2586 | Poly(I:C) | 2 | ug/mL | 3 | TNFb | 34.5 | 40 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | TNFb | 93.5 | 66 | |
RA1869 | IKK16 | 2.0 | uM | IL-1 alpha | 100 | ng/mL | 3 | TNFb | 99.0 | 64 | |
N2759 | 5z-7-oxozeaenol | 0.6 | uM | IL-1 alpha | 100 | ng/mL | 3 | TNFb | 103.0 | 63 |